# ONCOLYTICS BIOTECH INC. (ONCY) · Edgar & Edgarette company card

> Figures from the company's own SEC filings.

SEC CIK 1129928 · fiscal year ended — · 0 audited years read · [page](https://www.pops4.com/boards/company/ONCY) · [JSON](https://www.pops4.com/boards/company/ONCY.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | — |
| Revenue growth, 1 year | — |
| Revenue growth per year | — |
| Operating margin | — |
| Net margin | — |
| Operating cash flow | — |
| Capital spending | — |
| Free cash flow | — |
| Cash | — |
| Long-term debt | — |
| Total assets | — |
| Total equity | — |
| Equity ÷ assets | — |
| Return on equity | — |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures


## Edgarette's reading

The filings carry no annual revenue line Edgarette can read (common for banks and insurers, which report income differently). Nothing weighed, nothing guessed.

## Health Watch, last 12 months

- Item 3.01 Exchange listing notice or transfer: 1, latest 2026-07-24 ([filing](https://www.sec.gov/Archives/edgar/data/1129928/000112992826000047/0001129928-26-000047-index.htm))
- Item 4.01 Auditor change: 1, latest 2026-07-08 ([filing](https://www.sec.gov/Archives/edgar/data/1129928/000110465926081797/0001104659-26-081797-index.htm))
- Item 5.02 Director or officer change: 2, latest 2026-06-02 ([filing](https://www.sec.gov/Archives/edgar/data/1129928/000112992826000039/0001129928-26-000039-index.htm))

## Recent filings

- 8-K · filed 2026-11-04 · 8.01 Other Events · [filing](https://www.sec.gov/Archives/edgar/data/1129928/000112992826000078/0001129928-26-000078-index.htm)
- 8-K · filed 2026-10-27 · 8.01 Other Events · [filing](https://www.sec.gov/Archives/edgar/data/1129928/000112992826000076/0001129928-26-000076-index.htm)
- 8-K · filed 2026-10-20 · 8.01 Other Events · [filing](https://www.sec.gov/Archives/edgar/data/1129928/000112992826000074/0001129928-26-000074-index.htm)
- 8-K · filed 2026-10-14 · 8.01 Other Events · [filing](https://www.sec.gov/Archives/edgar/data/1129928/000112992826000072/0001129928-26-000072-index.htm)
- 8-K · filed 2026-10-13 · 8.01 Other Events · [filing](https://www.sec.gov/Archives/edgar/data/1129928/000112992826000070/0001129928-26-000070-index.htm)
- DEF 14A · filed 2026-10-06 · [filing](https://www.sec.gov/Archives/edgar/data/1129928/000112992826000066/0001129928-26-000066-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001129928.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1129928

## Cite

POPS4, Edgar & Edgarette: ONCOLYTICS BIOTECH INC. (ONCY) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/ONCY. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.